-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cardiff Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- Cardiff Oncology, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$12.6M, a 21.7% decline year-over-year.
- Cardiff Oncology, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$48.7M, a 7.13% decline year-over-year.
- Cardiff Oncology, Inc. annual Operating Income (Loss) for 2024 was -$48.7M, a 7.13% decline from 2023.
- Cardiff Oncology, Inc. annual Operating Income (Loss) for 2023 was -$45.4M, a 13.8% decline from 2022.
- Cardiff Oncology, Inc. annual Operating Income (Loss) for 2022 was -$39.9M, a 38.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)